April 9, 2026
Parkinson’s Disease Overview Parkinson disease (PD) is an adult-onset progressive neurodegenerative disorder, first described as “Shaking palsy” over 200 years ago by James Parkinson. While traditionally considered a motor system disorder based on the hallmark features of tremor, rigidity, and bradykinesia, PD is now recognized to be a complex disorder involving a wide range of…
May 21, 2024
What is Tardive Dyskinesia (TD)? Tardive Dyskinesia (TD) is a drug-induced involuntary movement disorder (DIMD) generally of the tongue, lower face, jaw, and extremities (but sometimes also pharyngeal, diaphragmatic, and trunk muscles) that can persist even after the discontinuation or alteration of neuroleptic medication regimens. Movements may be stereotypic (repetitive, purposeless), choreoathetotic (irregular, dance-like), or…
September 27, 2023
Addressing Polypharmacy Polypharmacy, the concurrent use of multiple medications by a single individual, is a common and concerning issue among older adult patients. As we age, the risk for developing chronic health conditions becomes more common, along with the number of medications used to manage these disease states. Polypharmacy in older adults has been linked…
March 17, 2023
AHA/ACC/HFSA Guideline for the Management of Heart Failure (HF) [American Heart Association/American College of Cardiology/Heart Failure Society of America 2022 Joint Committee Clinical Practice Guideline Update] What’s New from 2022? Stages of HF, Redefined [1] Emphasis on those who are at risk in staging → Focus on primary prevention in therapeutic management AHA/ACC/HFSA Staging Definition…
Categories
